207
Views
1
CrossRef citations to date
0
Altmetric
Reviews

Mesothelioma associated with use of drywall joint compound: a case series and review of literature

&
Pages 337-343 | Published online: 12 Nov 2013

References

  • Selikoff I, Lee D. Asbestos and disease. New York/San Francisco/London: Academic Press, Inc.; 1978.
  • Nicholson WJ. The carcinogenicity of chrysotile asbestos — a review. Ind Health. 2001;39:57–64.
  • Azuma K, Uchiyama I, Chiba Y, Okumura J. Mesothelioma risk and environmental exposure to asbestos: past and future trends in Japan. Int J Occup Environ Health. 2009;15:166–72.
  • Peto J, Decarli A, La Vecchia C, Levi F, Negri E. The European mesothelioma epidemic. Br J Cancer. 1999;79:666–72.
  • Carbone M, Ly BH, Dodson RF, Pagano I, Morris PT, Dogan UA, et al.. Malignant mesothelioma: facts, myths, and hypotheses. J Cell Physiol. 2012;227:44–58.
  • US Geological Survey. Mineral commodity summaries 2012. In: Interior USDot, editor. Reston (VA): US Geological Survey; 2012. p. 198.
  • LaDou J, Castleman B, Frank A, Gochfeld M, Greenberg M, Huff J, et al.. The case for a global ban on asbestos. Environ Health Perspect. 2010;118:897–901.
  • Paik NW, Walcott RJ, Brogan PA. Worker exposure to asbestos during removal of sprayed material and renovation activity in buildings containing sprayed material. Am Ind Hyg Assoc J. 1983;44:428–32.
  • Tossavainen A. Asbestos, asbestosis, and cancer: the Helsinki criteria for diagnosis and attribution. Consensus report. Scand J Work Environ Health. 1997;23:311–6.
  • Iwatsubo Y, Pairon JC, Boutin C, Menard O, Massin N, Caillaud D, et al.. Pleural mesothelioma: dose-response relation at low levels of asbestos exposure in a French population-based case–control study. Am J Epidemiol. 1998;148:133–42.
  • Hillerdal G. Mesothelioma: cases associated with non-occupational and low dose exposures. Occup Environ Med. 1999;56:505–13.
  • CPSC. Consumer patching compounds and artificial emberizing materials (embers and ash) containing respirable free-form asbestos. Fed. Register. 1977;42:63351–61.
  • Rohl AN, Langer AM, Selikoff IJ, Nicholson WJ. Exposure to asbestos in the use of consumer spackling, patching, and taping compounds. Science. 1975;189:551–3.
  • Fischbein A, Langer AM, Suzuki Y, Selikoff IJ. Carcinoma of the lung in a drywall taping worker report of a case. Toxicology Letters. 1978;2:231–6.
  • Fischbein A, Rohl AN, Langer AM, Selikoff IJ. Drywall construction and asbestos exposure. Am Ind Hyg Assoc J. 1979;40:402–7.
  • Soule R. Evaluation of exposure to asbestos during mixing and sanding of joint compounds. Report to Gypsum Association. Denver, CO, USA, 1973.
  • Verma DK, Middleton CG. Occupational exposure to asbestos in the drywall taping process. Am Ind Hyg Assoc J. 1980;41:264–9.
  • Dodson RF, Hammar SP. Epidemiology of asbestos-related diseases and the knowledge that led to what is known today. Asbestos: risk assessment, epidemiology, and health effects. 2nd edn. Boca Raton/London/New York: CRC Press, Taylor and Francis Group: 2011.
  • Hull MJ, Abraham JL, Case BW. Mesothelioma among Workers in Asbestiform Fiber-Bearing Talc Mines in New York State. Ann Occupl Hygiene 2002;46:132–5.
  • Nicholson WJ, Rohl A, Fischbein SA, Selikoff IJ. Occupational and Community Asbestos Exposure from Wallboard Finishing Compounds. Bull N Y Acad Med. 1975;51:1180.
  • Stern F, Lehman E, Ruder A. Mortality among unionized construction plasterers and cement masons. Am J Ind Med. 2001;39:373–88.
  • Selikoff IJ, Hammond EC, Seidman H. Mortality experience of insulation workers in the United States and Canada, 1943–1976. Ann N Y Acad Sci. 1979;330:91–116.
  • Lange JH, Thomulka KW. An evaluation of personal airborne asbestos exposure measurements during abatement of dry wall and floor tile/mastic. Int J Environ Health Res. 2000;10:5–19.
  • OSHA. Occupational exposure to asbestos. Washington (DC): Occupational Safety and Health Administration, US Department of Labor, 1983, p. 51086–140.
  • NIOSH. Method for Determination of Asbestos in Air Using Positive Phase Contrast Electron Microscopy. NIOSH Method 7400. Issued: 2/15/84; revision 3, 5/15/89: US Department of Health and Human Services, National Institute for Occupational Safety and Health, 1985.
  • Health Effects Institute AR. Asbestos in public and commercial buildings: a literature review and synthesis of current knowledge. Cambridge (MA): Health Effects Institute AR; 1991.
  • Rogers A. Cancer mortality and exposure to crocidolite. Br J Ind Med. 1990;47:286.
  • NIOSH. National Occupational Mortality Surveillance (NOMS). US Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, Division of Surveillance, Hazard Evaluation and Field Studies, Surveillance Branch; 2010.
  • Dodson RF, O’Sullivan M, Corn CJ, McLarty JW, Hammar SP. Analysis of asbestos fiber burden in lung tissue from mesothelioma patients. Ultrastruct Pathol. 1997;21:321–36.
  • Haber SE, Haber JM. Malignant mesothelioma: a clinical study of 238 cases. Ind Health. 2011;49:166–72.
  • Robinson C, Stern F, Halperin W, Venable H, Petersen M, Frazier T, et al.. Assessment of mortality in the construction industry in the United States, 1984–1986. Am J Ind Med. 1995;28:49–70.
  • Wang E, Dement JM, Lipscomb H. Mortality among North Carolina construction workers, 1988–1994. Appl Occup Environ Hyg. 1999;14:45–58.
  • Davis LK, Martin TR, Kligler B. Use of death certificates for mesothelioma surveillance. Public Health Rep. 1992;107:481–3.
  • Barnhart S, Keogh J, Cullen MR, Brodkin C, Liu D, Goodman G, et al.. The CARET asbestos-exposed cohort: baseline characteristics and comparison to other asbestos-exposed cohorts. Am J Ind Med. 1997;32:573–81.
  • NIOSH. Work-related lung disease surveillance report 1999. US Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health; 1999. p. 20–1 138–9.
  • Leigh J, Davidson P, Hendrie L, Berry D. Malignant mesothelioma in Australia, 1945–2000. Am J Ind Med. 2002;41:188–201.
  • Rodelsperger K, Jockel KH, Pohlabeln H, Romer W, Woitowitz HJ. Asbestos and man-made vitreous fibers as risk factors for diffuse malignant mesothelioma: results from a German hospital-based case-control study. Am J Ind Med. 2001;39:262–75.
  • McCoy M, Wolter M, Anderson K. Mesothelioma in Drywall Finishing Workers. J ASTM Int. 2011;8:1–14.
  • Brodkin C, Cullen M, Balmes J, Redlick C, Hammar S. Discussion on “Mesothelioma in Drywall Finishing Workers”, by McCoy MJ, Wolter ME, Anderson KE. [Journal of ASTM International Vol. 8, No. 1 (2011), Paper ID JAI102786]. J ASTM Int. 2011;8:1–3.
  • Gibbs GW, Berry G. Mesothelioma and asbestos. Regul Toxicol Pharmacol. 2008;52:S223–31.
  • Cullen MR. Chrysotile asbestos: enough is enough. Lancet. 1998;351:1377–8.
  • Cullen MR, Lopez-Carrillo L, Alli B, Pace PE, Shalat SL, Baloyi RS. Chrysotile asbestos and health in Zimbabwe: II. Health status survey of active miners and millers. Am J Ind Med. 1991;19:171–82.
  • Landrigan PJ, Nicholson WJ, Suzuki Y, Ladou J. The hazards of chrysotile asbestos: a critical review. Ind Health. 1999;37:271–80.
  • Lemen RA. Chrysotile asbestos as a cause of mesothelioma: application of the Hill causation model. Int J Occup Environ Health. 2004;10:233–9.
  • Bolton RE, Davis JM, Donaldson K, Wright A. Variations in the carcinogenicity of mineral fibres. Ann Occup Hyg. 1982;26:569–82.
  • Wagner JC, Berry G, Skidmore JW, Timbrell V. The effects of the inhalation of asbestos in rats. Br J Cancer. 1974;29:252–69.
  • Wagner JC, Berry G, Timbrell V. Mesotheliomata in rats after inoculation with asbestos and other materials. Br J Cancer. 1973;28:173–85.
  • Bouffant LL. Investigation and analysis of asbestos fibers and accompanying minerals in biological materials. Environ Health Perspect. 1974;9:149–53.
  • Suzuki Y, Yuen SR. Asbestos tissue burden study on human malignant mesothelioma. Ind Health. 2001;39:150–60.
  • Suzuki Y, Yuen SR. Asbestos fibers contributing to the induction of human malignant mesothelioma. Ann N Y Acad Sci. 2002;982:160–76.
  • Suzuki Y, Yuen SR, Ashley R. Short, thin asbestos fibers contribute to the development of human malignant mesothelioma: pathological evidence. Int J Hyg Environ Health. 2005;208:201–10.
  • Tweedale G, McCulloch J. Chrysophiles versus chrysophobes: the white asbestos controversy, 1950s–2004. Isis. 2004;95:239–59.
  • Smith AH, Wright CC. Chrysotile asbestos is the main cause of pleural mesothelioma. Am J Ind Med. 1996;30:252–66.
  • Bernstein DM, Donaldson K, Decker U, Gaering S, Kunzendorf P, Chevalier J, et al.. A biopersistence study following exposure to chrysotile asbestos alone or in combination with fine particles. Inhal Toxicol. 2008;20:1009–28.
  • Ferrante D, Bertolotti M, Todesco A, Mirabelli D, Terracini B, Magnani C. Cancer mortality and incidence of mesothelioma in a cohort of wives of asbestos workers in Casale Monferrato, Italy. Environ Health Perspect. 2007;115:1401–5.
  • Magnani C, Agudo A, Gonzalez CA, Andrion A, Calleja A, Chellini E, et al.. Multicentric study on malignant pleural mesothelioma and non-occupational exposure to asbestos. Br J Cancer. 2000;83:104–11.
  • Magnani C, Dalmasso P, Biggeri A, Ivaldi C, Mirabelli D, Terracini B. Increased risk of malignant mesothelioma of the pleura after residential or domestic exposure to asbestos: a case-control study in Casale Monferrato, Italy. Environ Health Perspect. 2001;109:915–9.
  • Landrigan PJ. A population of children at risk of exposure to asbestos in place. Ann N Y Acad Sci. 1991;643:283–6.
  • Pinto C, Soffritti M, Maltoni C. Ignored occupational risks of asbestos mesotheliomas. Med Lav. 1995;86:484–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.